PacBio and GeneDx Launch Research Collaboration with the University of Washington to Study Long-Read Whole Genome Sequencing for Increased Diagnostic Yield in Neonatal Care
/PRNewswire/ -- PacBio (Nasdaq: PACB), a leading developer of high-quality, highly accurate sequencing solutions and GeneDx (Nasdaq: WGS), a leader in...
Why GeneDx Holdings Stock Lagged the Market Today
A financial-engineering move about to be made by the company is an indication of some deep and challenging problems.
Why Shares of GeneDx Dropped Wednesday
The potential of a reverse split concerned investors.